Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
-
MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism
-
PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights
-
Consolidated Water to Attend the 37th Annual ROTH Conference, March 17-18, 2025
-
Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025
-
NEXE Innovations Makes Fourth Delivery to U.S.-Based EKOCUPS
-
MedBright AI Announces Strategic Investment into Algo8 Industrial AI
-
Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference
-
Oryzon Defines Phase III Trial Endpoints for Agitation and Aggression in BPD with Input From New Clinical Advisory Board
-
More Power, Less Bulk: Mophie’s New Powerstation Lineup Delivers High-Density, High-Capacity Charging
-
Enphase Energy Increases Deployments of Legacy NEM System Expansion Solution in California
-
TREATMENT.COM AI INC. ANNOUNCES UPSIZE ON LISTED ISSUER FINANCING EXEMPTION (LIFE) BOUGHT DEAL PRIVATE PLACEMENT
-
Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
-
ClearScale and Matilda Cloud Partner to Accelerate VMware Migration on AWS
-
Volaris Group Acquires Oceans HQ
-
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
-
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
-
Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results
-
Norden Discovers Gold Mineralized Porphyry Intrusion Returning 4.26 g/t Gold 850 Metres East of Sunrise Mine at the Smart Creek Project, Montana
-
Integral Metals Advances Woods Creek Exploration with Additional Geochemical and Mineralogical Analysis
-
Spectral Medical Provides February Tigris Trial Update
-
Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
-
GCL Plans to Strengthen Gaming Portfolio with Potential 20% Stake Acquisition in LEAP for Exclusive Global Publishing Rights for Upcoming Game “Realm of Ink”
-
Rezolve Ai Poised to Capitalize on U.S. Strategic Cryptocurrency Reserve Initiative
-
Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication
-
Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update
-
Encore Capital Group to Meet with Investors and Present at the Raymond James 46th Annual Institutional Investors Conference
-
HCI Group Revamps Operating Structure and Introduces Exzeo Group Inc.
-
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones
-
Playtika Holding Corp. to Participate in Upcoming Investor Conferences in First Quarter 2025
-
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
-
Cove Capital and Kazakhstan’s National Mining Company Formalize Joint Venture to Develop the Akbulak Rare Earth Project
-
First Busey Corporation Completes Acquisition of CrossFirst Bankshares, Inc. and CrossFirst Bank
-
Dave and Coastal Community Bank Announce Strategic Partnership
-
CN and Iowa Northern Railway Officially Join their Operations
-
MediWound to Report Fourth Quarter and Full Year 2024 Financial Results
-
Australian Oilseeds Announces Appointment of Amarjeet Singh as Chief Financial Officer
-
North American Construction Group Ltd. Reschedules Fourth Quarter Results Conference Call and Webcast
-
Baker Hughes, Frontier Infrastructure Announce Partnership to Accelerate Development of Carbon Capture and Storage, Data Center Projects in the U.S.
-
NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program
-
Connect Biopharma to Present at Two Upcoming Investor Conferences
-
LENZ Therapeutics to Host Commercial Day on April 15, 2025
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
-
Design Therapeutics to Participate in Leerink’s Global Healthcare Conference
-
TikTok insights now available within the Meltwater platform
-
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
-
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025
-
Andrea White Named Chief Human Resources Officer of Sonoco
-
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
-
Alliance Witan PLC - Net Asset Value
